⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL27892347 | 0.87 | FDPS (0.30) | — | |
| SCHEMBL8615162 | 0.78 | FDPS (0.50) | — | |
| SCHEMBL37063 | 0.78 | — | — | |
| SCHEMBL28564830 | 0.75 | — | — | |
| SCHEMBL10036890 | 0.75 | — | — | |
| SCHEMBL11749825 | 0.75 | — | — | |
| SCHEMBL1065048 | 0.75 | — | — | |
| SCHEMBL5141559 | 0.75 | — | — | |
| SCHEMBL1098223 | 0.75 | — | — | |
| Ammonia Solution, Strong SCHEMBL4163138 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024493-A1 | CAS ENDONUCLEASES AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2024073678-A2 | PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE | OMEGA THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | claimed |
| EP-4314297-A1 | TARGETING ONCOGENTIC MUTATIONS WITH DUAL-CLEAVING ENDONUCLEASE | Specific Biologics Inc. (CA) | 2024-02-07 | — | — | EP | claimed |
| US-20240018293-A1 | Use of Raw Gel in Formulations on the Basis of Polyurethane Dispersions | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-18 | — | — | US | claimed |
| EP-4301859-A1 | ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | Code Biotherapeutics, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| EP-4232492-A1 | USE OF RAW GEL IN FORMULATIONS ON THE BASIS OF POLYURETHANE DISPERSIONS | Covestro Deutschland AG (DE) | 2023-08-30 | — | — | EP | claimed |
| CN-116472299-A | Use of fresh sols in polyurethane dispersion-based formulations | 科思创德国股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| WO-2022200858-A1 | TARGETING ONCOGENTIC MUTATIONS WITH DUAL-CLEAVING ENDONUCLEASE | SPECIFIC BIOLOGICS INC. (CA) | 2022-09-29 | — | — | WO | claimed |
| WO-2022187586-A1 | ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | CODE BIOTHERAPEUTICS, INC. (US) | 2022-09-09 | — | — | WO | claimed |
| CN-109852223-A | It is a kind of for coating woodenware surface to realize the aqueous formulation of nature haptic effect | 兰州科天水性高分子材料有限公司 | 2019-06-07 | — | — | CN | claimed |
| EP-1611249-A1 | OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA | ISIS PHARMACEUTICALS, INC. (US) | 2006-01-04 | — | — | EP | claimed |
| WO-2005017009-A1 | HYDROLYTICALLY STABLE ISOELECTRIC HYDROGEL COMPOSITIONS | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 2005-02-24 | — | — | WO | claimed |
| WO-2004097049-A1 | OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA | ISIS PHARMACEUTICALS, INC. (US) | 2004-11-11 | — | — | WO | claimed |
| EP-1379214-A1 | HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING SAME | L'OREAL, S.A. (FR) | 2004-01-14 | — | — | EP | claimed |
| US-20030037384-A1 | Compositions comprising at least one hydroxide compound and at least one oxidizing agent, and methods to straighten curly hair | L'OREAL S.A. (FR) | 2003-02-27 | — | — | US | claimed |
| WO-2003015725-A2 | COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE REDUCING AGENT, AND METHODS FOR RELAXING HAIR | L'OREAL S.A. (FR) | 2003-02-27 | — | — | WO | claimed |
| WO-2003015732-A1 | COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE OXIDIZING AGENT, AND METHODS TO STRAIGHTEN CURLY HAIR | L'OREAL S.A. (FR) | 2003-02-27 | — | — | WO | claimed |
| US-20030033677-A1 | Compositions comprising at least one hydroxide compound and at least one reducing agent, and methods for relaxing hair | L'OREAL S.A. (FR) | 2003-02-20 | — | — | US | claimed |
| US-20020159962-A1 | Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same | L'OREAL S.A. (FR) | 2002-10-31 | — | — | US | claimed |
| WO-2002067875-A1 | HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING THE SAME | L'OREAL S.A. (FR) | 2002-09-06 | — | — | WO | claimed |